Serum lactate dehydrogenase to albumin ratio as a predictor of severity in COVID-19 patients

Authors

  • Ayesha Siddeequa Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India
  • Jyotsna Volturi Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India
  • Azmath Kulsum Fatima Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India
  • M.D Dawood Suleman Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20223643

Keywords:

COVID-19, LDH, Albumin, Ratio, Severity, Predictor

Abstract

Background: COVID-19 infection, discovered in Wuhan, China, engulfed vast population in most of the countries in a very short span, ranging from aymptomatic infection to acute respiratory distress syndrome, multiorgan failures and death. Individual studies on serum lactate dehydrogenase and albumin showed association with severity of disease. The purpose of present study is intended to predict the association of combined lactate dehydrogenase (LDH) to Albumin ratio with severity of COVID-19.

Methods: A retrospective observational study was carried on already confirmed cases of covid 19 infection from July, 2021 to December, 2021 in Gandhi hospital, Secunderabad. History, clinical features and laboratory findings including LDH: Alb ratio was noted. Cases with known history of carcinomas, chronic kidney disease, chronic liver/lung disease, coronary artery disease, alcoholics were not included. Cases were divided into mild, moderate and severe based on National clinical management protocol for COVID-19. Data was analyzed using SPSS/Medcalc software.

Results: LDH and LDH: Alb ratio was significantly raised with the severity of the disease. The AUC in ROC analysis of LDH: Alb ratio was 0.75 compared to 0.71 and 0.62 individually for LDH & Alb respectively; indicating ratio was superior to that of individual parameters.

Conclusion: The present study shows significant correlation between LDH: Alb ratio with severity of COVID-19 infection. LDH: Alb ratio could be an easily available tool to predict COVID-19 severity.

Author Biographies

Ayesha Siddeequa, Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India

Post graduate, Department of Biochemistry, Gandhi Medical College

Jyotsna Volturi, Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India

Assistant professor, Department of Biochemistry, Gandhi Medical College

Azmath Kulsum Fatima, Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India

Post graduate, Department of Biochemistry, Gandhi Medical College

M.D Dawood Suleman, Department of Biochemistry, Gandhi Medical College, Secunderabad, Telangana, India

Professor and HOD, Department of Biochemistry, Gandhi Medical College

References

Page J, Hinshaw D, McKay B. In hunt for Covid-19 origin, patient zero points to second Wuhan Market The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there. Wall Street J. 2021.

Zimmer C. The secret life of a coronavirus: an oily, 100-nanometer-wide bubble of genes has killed more than two million people and reshaped the world. Scientists don't quite know what to make of it. Available at: https://www.nytimes.com/ 2021/02/26/opinion/sunday/coronavirus-alive-dead.html. Accessed on 20 November 2021.

Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

Yu SL, Xu LT, Qi Q, Geng YW, Chen H, Meng ZQ, et al. Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy. Sci Rep. 2017;7:45194.

Inamura N, Miyashita N, Hasegawa S, Kato A, Fukuda Y, Saitoh A, et al. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. J Infect Chemother. 2014;20(4):270-3.

Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respr J. 1996;9(8):1736-42.

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020.

Zhang R, Ouyang H, Fu L, Wang S, Han J, Huang K, Jia M, et al. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol. 2020;30:4417-26.

Li C, Ye J, Chen Q, Hu W, Wang L, Fan Y, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging. 2020;12(15):15670-81.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID19 inpatients in Wuhan. J Aller Clin Immunol. 2020;146(1):110-8

Infusino I, Panteghini M. Serum albumin: accuracy and clinical use. Clin Chim Acta. 2013;419:15-8.

Jellinge ME, Henriksen DP, Hallas P, Brabrand M. Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study. PLoS One. 2014;9(8):e105983

De la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, et al. Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study. Microorganisms. 2020;8(8):1106.

Mingqing L, Luping Z, Yingli Z. Lactate dehydrogenase to albumin ratio as a predictive factor of COVID-19 patients' outcome; a cross-sectional study. Arch Acad Emerg Med. 2022;10(1):e63.

Downloads

Published

2022-12-30

How to Cite

Siddeequa, A., Volturi, J., Fatima, A. K., & Suleman, M. D. (2022). Serum lactate dehydrogenase to albumin ratio as a predictor of severity in COVID-19 patients. International Journal of Research in Medical Sciences, 11(1), 238–242. https://doi.org/10.18203/2320-6012.ijrms20223643

Issue

Section

Original Research Articles